GFRAL and metabolic disease: Elevated circulating GDF15 levels are often observed in pathological states such as cancer, cardiovascular disease, and metabolic disorders, where it acts as an anorexigenic signal via its receptor GFRAL in the hindbrain to suppress appetite [36].